Transcutaneous oxygen pressure (TcPO2): A novel diagnostic tool for peripheral neuropathy in type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 105, Issue 3, 2014, Pages 336-343

  Deng, Wuquan ^a,b   Dong, Xiaoying ^a   Zhang, Yuping ^a   Jiang, Youzhao ^a   Lu, Debin ^a   Wu, Qinan ^a   Liang, Ziwen ^a   Yang, Gangyi ^b   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic peripheral neuropathy; Nerve conduction study; Transcutaneous oxygen pressure

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; CYSTATIN C; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRESSURE MEASUREMENT; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SITTING; SUPINE POSITION; TRANSCUTANEOUS OXYGEN PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; BLOOD; BODY POSTURE; COMPLICATION; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; MIDDLE AGED; PHYSIOLOGY; TRANSCUTANEOUS OXYGEN MONITORING;

AGED; BIOLOGICAL MARKERS; BLOOD GAS MONITORING, TRANSCUTANEOUS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POSTURE; SENSITIVITY AND SPECIFICITY;

EID: 84921626700     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.05.012     Document Type: Article

References (28)

1. Raman R., Gupta A., Krishna S., Kulothungan V., Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications 2012, 26:123-128.
2. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P., et al. New diagnostic tests for diabetic distal symmetric polyneuropathy. Diabetes Care 2010, 33:2285-2293.
3. Kim S.S., Won J.C., Kwon H.S., Kim C.H., Lee J.H., Park T.S., et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract 2014, 103:522-529.
4. Papanas N., Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications 2011, 25:44-51.
5. Nabuurs-Franssen M.H., Houben A.J., Tooke J.E., Schaper N.C. The effect of polyneuropathy on foot microcirculation in type II diabetes. Diabetologia 2002, 45:1164-1171.
6. Tesfaye S., Harris N., Jakubowski J.J., Mody C., Wilson R.M., Rennie I.G., et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993, 36:1266-1274.
7. Vincent A.M., Callaghan B.C., Smith A.L., Feldman E.L. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011, 7:573-583.
8. Tesfaye S., Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 2012, 28(Suppl. 1):8-14.
9. Sun P.C., Kuo C.D., Chi L.Y., Lin H.D., Wei S.H., Chen C.S. Microcirculatory vasomotor changes are associated with severity of peripheral neuropathy in patients with type 2 diabetes. Diab Vasc Dis Res 2013, 10:270-276.
10. de Meijer V.E., Van't Sant H.P., Spronk S., Kusters F.J., den Hoed P.T. Reference value of transcutaneous oxygen measurement in diabetic patients compared with nondiabetic patients. J Vasc Surg 2008, 48:382-388.
11. Zimny S., Dessel F., Ehren M., Pfohl M., Schatz H. Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diabetes Care 2001, 24:1810-1814.
12. American Diabetes Association, Asbury A.K., Porte D., Griffin J., Ward J.D., Sima A.A.F., et al. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 1992, 15(Suppl. 3):1081-1107.
13. Mete T., Aydin Y., Saka M., Cinar Yavuz H., Bilen S., Yalcin Y., et al. Comparison of efficiencies of Michigan neuropathy screening instrument, neurothesiometer, and electromyography for diagnosis of diabetic neuropathy. Int J Endocrinol 2013, 2013:821745.
14. Papanas N., Giassakis G., Papatheodorou K., Papazoglou D., Monastiriotis C., Christakidis D., et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 2007, 21:353-358.
15. Owolabi M.O., Ipadeola A. Total vascular risk as a strong correlate of severity of diabetic peripheral neuropathy in Nigerian Africans. Ethn Dis 2012, 22:106-112.
16. Tesfaye S., Chaturvedi N., Eaton S.E., Ward J.D., Manes C., Ionescu-Tirgoviste C., et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005, 352:341-350.
17. Cameron N.E., Eaton S.E., Cotter M.A., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001, 44:1973-1988.
18. Krolewski A.S., Warram J.H., Forsblom C., Smiles A.M., Thorn L., Skupien J., et al. Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care 2012, 35:2311-2316.
19. El Boghdady N.A., Badr G.A. Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct 2012, 30:328-334.
20. Iwase M., Imoto H., Murata A., Nakamura U., Nohara S., Uchizono Y., et al. Altered postural regulation of foot skin oxygenation and blood flow in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007, 115:444-447.
21. Chao C.Y., Zheng Y.P., Cheing G.L. The association between skin blood flow and edema on epidermal thickness in the diabetic foot. Diabetes Technol Ther 2012, 14:602-609.
22. Flynn M.D., Tooke J.E. Diabetic neuropathy and the microcirculation. Diabet Med 1995, 12:298-301.
23. Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I., et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005, 48:578-585.
24. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
25. Sung J.Y., Park S.B., Liu Y.T., Kwai N., Arnold R., Krishnan A.V., et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes 2012, 61:1592-1598.
26. Chéliout-Héraut F., Zrek N., Khemliche H., Varnet O., Seret-Begue D., Martinez M., et al. Exploration of small fibers for testing diabetic neuropathies. Joint Bone Spine 2005, 72:412-415.
27. Dyck P.J., Herrmann D.N., Staff N.P., Dyck P.J. Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies. Diabetes 2013, 62:3677-3686.
28. Parson H.K., Nguyen V.T., Orciga M.A., Boyd A.L., Casellini C.M., Vinik A.I. Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function. Diabetes Technol Ther 2013, 15:150-157.